共 19 条
- [3] Public Health Outcomes May Differ After Switching from Brand-Name to Generic Angiotensin II Receptor Blockers Drugs in R&D, 2020, 20 : 135 - 145
- [7] Trends in Hospital Visits for Generic and Brand-Name Warfarin Users in Québec, Canada: A Population-Based Time Series Analysis American Journal of Cardiovascular Drugs, 2019, 19 : 287 - 297
- [9] Evaluation of Clinical and Safety Outcomes Associated with Conversion from Brand-Name to Generic Tacrolimus in Transplant Recipients Enrolled in an Integrated Health Care System PHARMACOTHERAPY, 2012, 32 (11): : 981 - 987